| 12350270 |
Antimalarial agents |
Alan Cowman, Manuel de Lera Ruiz, Paola Favuzza, Zhuyan Guo, Bin Hu +9 more |
2025-07-08 |
|
| 12338219 |
Antimalarial agents |
Manuel de Lera Ruiz, Zhuyan Guo, Bin Hu, Michael J. Kelly, III, Zhiyu Lei +4 more |
2025-06-24 |
|
| 11958864 |
Tetracyclic heterocycle compounds useful as HIV integrase inhibitors |
Timothy J. Hartingh, Tao Yu, Yonglian Zhang |
2024-04-16 |
$245,789,000 |
| 11884683 |
Tricyclic heterocycle compounds useful as HIV integrase inhibitors |
Tao Yu, Alan Whitehead, Yili Chen, Chunrui Sun, Zhiyong Hu +2 more |
2024-01-30 |
$174,751,000 |
| 11358711 |
Tetracyclic heterocycle compounds useful as HIV integrase inhibitors |
Thomas H. Graham, Tao Yu, Yonglian Zhang |
2022-06-14 |
$379,003,000 |
| 10934312 |
Tricyclic heterocycle compounds useful as HIV integrase inhibitors |
Thomas H. Graham, Tao Yu, Sherman T. Waddell |
2021-03-02 |
$166,587,000 |
| 10829499 |
Tetracyclic heterocycle compounds useful as HIV integrase inhibitors |
Thomas H. Graham, Tao Yu, Yonglian Zhang |
2020-11-10 |
$228,309,000 |
| 10786488 |
Substituted quinolizine derivatives useful as HIV integrase inhibitors |
Tao Yu, Alan Whitehead, James M. Apgar, Izzat T. Raheem, Guizhen Dong +2 more |
2020-09-29 |
$380,466,000 |
| 10696639 |
Heterocyclic compounds as HIV protease inhibitors |
Tanweer A. Khan, Elizabeth M. Smith, Peter D. Williams, Catherine M. Wiscount, Brian McKittrick |
2020-06-30 |
$164,171,000 |
| 10624912 |
Spirocyclic Pyridotriazine Derivatives useful as HIV integrase inhibitors |
Thomas H. Graham, Tao Yu, Sherman T. Waddell, Andrew Stamford, Wengsheng Liu +2 more |
2020-04-21 |
$179,652,000 |
| 10548910 |
Amido-substituted pyridotriazine derivatives useful as HIV integrase inhibitors |
Thomas H. Graham, Tao Yu, Sherman T. Waddell, Andrew Stamford, Wensheng Liu +2 more |
2020-02-04 |
$130,007,000 |
| 10544155 |
Spirocyclic quinolizine derivatives useful as HIV integrase inhibitors |
Yonglian Zhang, Sherman T. Waddell, Tao Yu, Andrew Stamford |
2020-01-28 |
$79,189,000 |
| 10479801 |
Tetracyclic heterocycle compounds useful as HIV integrase inhibitors |
Thomas H. Graham, Tao Yu, Yonglian Zhang |
2019-11-19 |
$484,220,000 |
| 10233193 |
Fused tricyclic heterocyclic compounds useful for treating HIV infection |
Tao Yu, Thomas H. Graham, Sherman T. Waddell, Andrew Stamford, John M. Sanders +3 more |
2019-03-19 |
$169,765,000 |
| 10138255 |
Piperazine derivatives as HIV protease inhibitors |
Peter D. Williams, Christopher James Bungard, David Jonathan Bennett, Sherman T. Waddell, Gregori J. Morriello +13 more |
2018-11-27 |
$94,550,000 |
| 10081647 |
Phosphate substituted quinolizine derivatives useful as HIV integrase inhibitors |
Tao Yu, Sherman T. Waddell, Thomas H. Graham, Hong Li, Izzat T. Raheem +1 more |
2018-09-25 |
$93,342,000 |
| 9994587 |
HIV protease inhibitors |
David Jonathan Bennett, Christopher James Bungard, Thomas J. Greshock, M. Katharine Holloway, Peter D. Williams +9 more |
2018-06-12 |
$89,973,000 |
| 9840478 |
Piperazine derivatives as HIV protease inhibitors |
Peter D. Williams, David Jonathan Bennett, Christopher James Bungard, Lehua Chang, Michael P. Dwyer +17 more |
2017-12-12 |
$85,898,000 |
| 9834526 |
HIV protease inhibitors |
Christian Beaulieu, David Jonathan Bennett, Christopher James Bungard, Sheldon Crane, Thomas J. Greshock +7 more |
2017-12-05 |
$49,639,000 |
| 9738661 |
HCV NS3 protease inhibitors |
Nigel J. Liverton, Vincenzo Summa, Steven Harper, Joseph J. Romano, Michael T. Rudd |
2017-08-22 |
$79,902,000 |
| 9737545 |
HIV protease inhibitors |
Christian Beaulieu, David Jonathan Bennett, Christopher James Bungard, Sheldon Crane, Thomas J. Greshock +11 more |
2017-08-22 |
$79,902,000 |
| 9718818 |
Compounds inhibiting leucine-rich repeat kinase enzyme activity |
Duane DeMong, Thomas J. Greshock, Ronald K. Chang, Xing Dai, Hong Liu +4 more |
2017-08-01 |
$68,609,000 |
| 9440952 |
Compounds inhibiting leucine-rich repeat kinase enzyme activity |
Michael Miller, Kallol Basu, Duane DeMong, Jack D. Scott, Hong Liu +9 more |
2016-09-13 |
$142,282,000 |
| 9328138 |
HCV NS3 protease inhibitors |
Michael T. Rudd, Nigel J. Liverton, Christiane Grisé-Bard, Marie-Christine Brochu, Sylvie Charron +12 more |
2016-05-03 |
$59,926,000 |
| 9315475 |
HIV protease inhibitors |
Christian Beaulieu, David Jonathan Bennett, Christopher James Bungard, Ronald K. Chang, Sheldon Crane +16 more |
2016-04-19 |
$73,692,000 |
